We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01699841
Recruitment Status : Completed
First Posted : October 4, 2012
Last Update Posted : November 1, 2017
Information provided by (Responsible Party):
Cornell University

Brief Summary:
The purpose of this study is to understand how breast milk may protect infants from infection and promote favorable immunological, growth and development outcomes. By following mothers and their infants, we will evaluate the important interactions between infant immune responses and infectious disease events in relation to breast milk composition and feeding patterns. Our aim is to identify a set of predictive factors corresponding to healthy early infant growth and development in this setting in Northern Tanzania.

Condition or disease
HIV Malnutrition Cryptosporidiosis

Study Type : Observational
Estimated Enrollment : 208 participants
Observational Model: Cohort
Time Perspective: Prospective
Actual Study Start Date : April 2012
Primary Completion Date : June 15, 2013
Study Completion Date : June 30, 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

HIV+ and HIV- mothers and their infants

Primary Outcome Measures :
  1. Breast milk composition [ Time Frame: Up to 6 months post-partum ]

Secondary Outcome Measures :
  1. Infant anthropometric measures [ Time Frame: Up to 6 months of age ]
  2. Infant infectious disease events [ Time Frame: Up to 6 months of age ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
HIV+ and HIV- mothers and their infants attending a semi-rural clinic and/or rural dispensaries from birth to 6 months of infant age in north western Tanzania.

Inclusion Criteria:

  • Informed consent provided by mothers, and parental consent on behalf of their infants
  • Confirmed maternal HIV status (HIV-1, HIV-2 or HIV-Dual seropositive or HIV-seronegative)
  • Stated intention to remain in the clinic catchment area ≥6 months post-partum
  • Singleton birth

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01699841

Kisesa Health Centre
Kisesa, Tanzania
Sponsors and Collaborators
Cornell University

Responsible Party: Cornell University
ClinicalTrials.gov Identifier: NCT01699841     History of Changes
Other Study ID Numbers: IRB 1111002616
First Posted: October 4, 2012    Key Record Dates
Last Update Posted: November 1, 2017
Last Verified: October 2017

Additional relevant MeSH terms:
Nutrition Disorders
Intestinal Diseases, Parasitic
Parasitic Diseases
Protozoan Infections, Animal
Parasitic Diseases, Animal
Protozoan Infections
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases